Richard Wade-Martins, MA, DPhil, graduated from the University of Cambridge and obtained his DPhil from the University of Oxford. In 2000 he moved to Massachusetts General Hospital, Harvard Medical School, returning to Oxford to start his own group in 2004. In 2007 Dr. Wade-Martins obtained a faculty position in the Department of Physiology, Anatomy and Genetics at the University of Oxford.
He works on the molecular mechanisms underlying common neurodegenerative diseases, such as Parkinson’s disease. His work combines the development of induced pluripotent stem (iPS) cell-derived neuronal models of disease, the generation and analysis of novel transgenic and knockout models, and studies on human post-mortem brain tissue. His research questions cover the functional and genetic mechanisms underlying key neurodegeneration disease loci, such as alpha-synuclein (SNCA). Dr. Wade-Martins heads the Molecular Neurodegeneration Research Laboratory and is director of the Oxford Parkinson’s Disease Centre, a new multi-disciplinary research initiative supported by the Monument Discovery Award from Parkinson’s UK.